vs

Side-by-side financial comparison of Armour Residential REIT, Inc. (ARR) and GERON CORP (GERN). Click either name above to swap in a different company.

Armour Residential REIT, Inc. is the larger business by last-quarter revenue ($50.4M vs $47.2M, roughly 1.1× GERON CORP). Armour Residential REIT, Inc. runs the higher net margin — 420.2% vs -39.0%, a 459.3% gap on every dollar of revenue. On growth, Armour Residential REIT, Inc. posted the faster year-over-year revenue change (297.9% vs 67.1%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 108.0%).

Armour Residential REIT, Inc. is a U.S.-based real estate investment trust that primarily invests in agency residential mortgage-backed securities guaranteed by U.S. government-sponsored entities. It focuses on generating consistent long-term net income for shareholders via strategic asset management and active interest rate risk mitigation.

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

ARR vs GERN — Head-to-Head

Bigger by revenue
ARR
ARR
1.1× larger
ARR
$50.4M
$47.2M
GERN
Growing faster (revenue YoY)
ARR
ARR
+230.8% gap
ARR
297.9%
67.1%
GERN
Higher net margin
ARR
ARR
459.3% more per $
ARR
420.2%
-39.0%
GERN
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
108.0%
ARR

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ARR
ARR
GERN
GERN
Revenue
$50.4M
$47.2M
Net Profit
$211.7M
$-18.4M
Gross Margin
Operating Margin
-29.4%
Net Margin
420.2%
-39.0%
Revenue YoY
297.9%
67.1%
Net Profit YoY
555.9%
30.3%
EPS (diluted)
$2.43
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARR
ARR
GERN
GERN
Q4 25
$50.4M
Q3 25
$38.5M
$47.2M
Q2 25
$33.1M
$49.0M
Q1 25
$36.3M
$39.6M
Q4 24
$12.7M
Q3 24
$28.3M
Q2 24
$7.0M
$882.0K
Q1 24
$304.0K
Net Profit
ARR
ARR
GERN
GERN
Q4 25
$211.7M
Q3 25
$159.3M
$-18.4M
Q2 25
$-75.6M
$-16.4M
Q1 25
$27.3M
$-19.8M
Q4 24
$-46.4M
Q3 24
$-26.4M
Q2 24
$-48.4M
$-67.4M
Q1 24
$-55.4M
Operating Margin
ARR
ARR
GERN
GERN
Q4 25
Q3 25
-29.4%
Q2 25
-25.4%
Q1 25
-42.2%
Q4 24
Q3 24
-99.8%
Q2 24
-7860.9%
Q1 24
-18465.1%
Net Margin
ARR
ARR
GERN
GERN
Q4 25
420.2%
Q3 25
413.5%
-39.0%
Q2 25
-228.4%
-33.4%
Q1 25
75.2%
-50.1%
Q4 24
-366.8%
Q3 24
-93.5%
Q2 24
-693.8%
-7639.8%
Q1 24
-18220.4%
EPS (diluted)
ARR
ARR
GERN
GERN
Q4 25
$2.43
Q3 25
$1.49
$-0.03
Q2 25
$-0.94
$-0.02
Q1 25
$0.32
$-0.03
Q4 24
$-0.91
Q3 24
$-0.04
Q2 24
$-1.05
$-0.10
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARR
ARR
GERN
GERN
Cash + ST InvestmentsLiquidity on hand
$63.3M
$78.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.3B
$248.7M
Total Assets
$21.0B
$567.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARR
ARR
GERN
GERN
Q4 25
$63.3M
Q3 25
$44.2M
$78.1M
Q2 25
$141.2M
$77.7M
Q1 25
$49.1M
$83.7M
Q4 24
$68.0M
Q3 24
$60.3M
Q2 24
$126.6M
$116.9M
Q1 24
$189.8M
Stockholders' Equity
ARR
ARR
GERN
GERN
Q4 25
$2.3B
Q3 25
$2.1B
$248.7M
Q2 25
$1.7B
$259.5M
Q1 25
$1.7B
$268.2M
Q4 24
$1.4B
Q3 24
$292.3M
Q2 24
$1.2B
$306.7M
Q1 24
$344.9M
Total Assets
ARR
ARR
GERN
GERN
Q4 25
$21.0B
Q3 25
$19.4B
$567.4M
Q2 25
$16.2B
$555.2M
Q1 25
$15.5B
$562.5M
Q4 24
$13.5B
Q3 24
$444.9M
Q2 24
$10.1B
$449.4M
Q1 24
$482.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARR
ARR
GERN
GERN
Operating Cash FlowLast quarter
$124.2M
$-13.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.59×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARR
ARR
GERN
GERN
Q4 25
$124.2M
Q3 25
$-37.8M
$-13.6M
Q2 25
$25.0M
$-27.4M
Q1 25
$101.5M
$-48.0M
Q4 24
$261.5M
Q3 24
$-58.9M
Q2 24
$27.1M
$-53.5M
Q1 24
$-62.3M
Free Cash Flow
ARR
ARR
GERN
GERN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-53.7M
Q1 24
$-62.9M
FCF Margin
ARR
ARR
GERN
GERN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-6086.6%
Q1 24
-20680.3%
Capex Intensity
ARR
ARR
GERN
GERN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
23.4%
Q1 24
202.3%
Cash Conversion
ARR
ARR
GERN
GERN
Q4 25
0.59×
Q3 25
-0.24×
Q2 25
Q1 25
3.71×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons